skip to main content
Hide All The Ads With a Yearly Membership Subscribe ▶

S. 3751 (111th): Stem Cell Therapeutic and Research Reauthorization Act of 2010

React to this bill with an emoji

(About Ads | Hide These Ads)

A bill to amend the Stem Cell Therapeutic and Research Act of 2005.

The federal budget process occurs in two stages: appropriations, which set overall spending limits by agency or program, and authorizations, which direct how federal funds should (or should not) be used. Appropriation and authorization provisions are typically made for single fiscal years. A reauthorization bill like this one renews the authorizations of an expiring law.

Sponsor and status

Photo of sponsor Orrin Hatch

Orrin Hatch

Sponsor. Senator for Utah. Republican.

Thumbnail of bill text
Read Text »
Last Updated: Oct 2, 2010
Length: 6 pages
Introduced
Aug 5, 2010
111th Congress (2009–2010)
Status

Enacted — Signed by the President on Oct 8, 2010

This bill was enacted after being signed by the President on October 8, 2010.

Law
Pub.L. 111-264
Cosponsors

12 Cosponsors (8 Democrats, 4 Republicans)

Source
Congress.gov

Incorporated legislation

This bill incorporates provisions from:

H.R. 6081: Stem Cell Therapeutic and Research Reauthorization Act of 2010

Ordered Reported on Sep 23, 2010. 100% incorporated. (compare text)

H.R. 6083: Stem Cell Therapeutic and Research Reauthorization Act of 2010

Introduced on Aug 10, 2010. 66% incorporated. (compare text)

(About Ads | Hide These Ads)

History

Aug 5, 2010
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

Sep 23, 2010
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Read Updated Text » See Changes »

Sep 28, 2010
 
Passed Senate (House next)

The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made.

Read Updated Text » See Changes »

Sep 30, 2010
 
Passed House

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.

Read Updated Text » See Changes »

Oct 8, 2010
 
Enacted — Signed by the President

The President signed the bill and it became law.

Nov 16, 2015
 
Reintroduced Bill — Introduced

This activity took place on a related bill, S. 2282 (114th).

S. 3751 (111th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number S. 3751. This is the one from the 111th Congress.

This bill was introduced in the 111th Congress, which met from Jan 6, 2009 to Dec 22, 2010. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 3751 — 111th Congress: Stem Cell Therapeutic and Research Reauthorization Act of 2010.” www.GovTrack.us. 2010. September 27, 2023 <https://www.govtrack.us/congress/bills/111/s3751>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.